---
figid: PMC2275695__BIO.118380.wc.f2
figlink: /pmc/articles/PMC2275695/figure/fig2/
number: F2
caption: 'A. laidlawii lipid biosynthetic network. (A) The biochemical network. The
  main lipids in the plasma membrane of A. laidlawii A-EF22 are (): phosphatidylglycerol
  (PG), diacylglycerol (DAG), monoglucosyl-DAG (MGlcDAG), diglucosyl-DAG (DGlcDAG),
  and glycerophosphoryl-DGlcDAG (GPDGlcDAG). Phosphatidic acid (PA), the liponuleotide
  CDP-DAG, and PG-phosphate (PGP) are lipid intermediates. The top branch is the PG
  pathway and the bottom branch is the glucolipid pathway. The abbreviated soluble
  reactants are glucose (Glc) and UDP-Glc, glycerol-3-phosphate (G3P), the inorganic
  phosphate ions Pi and PPi, and the nucleotide CTP. R indicates an acyl chain. Six
  of the seven enzymes have irreversible rate equations. A. laidlawii also synthesizes
  three monoacyl derivatives of the glucolipids: monoacyl-MGlcDAG (MAMGlcDAG), monoacyl-DGlcDAG
  (MADGlcDAG), and monoacyl-bisglycerophosphoryl-DGlcDAG (MABGPDGlcDAG) (). However,
  these lipids have been excluded from the model as they are not always synthesized
  () and their biosynthetic pathways have been postulated, but are not known (). (B)
  A biophysical picture of the network. Lipids are color coded according to their
  Js, which is linked to their molecular shape as shown. The same color code is used
  to show that the activity of MGS and DGS increases when the plasma membrane has
  a large negative  It can be seen, for instance, that in the case of the lower pathway
  the effect of MGS and DGS is to increase the effective size of the headgroup of
  the lipid upon which they are acting and therefore systematically increase the value
  of Js among DAG, MGlcDAG, and DGlcDAG. By controlling the rate of the steps between
  DAG/MGlcDAG and MGlcDAG/DGlcDAG, the system is capable of regulating A. laidlawii
  also synthesizes three monoacyl-derivatives of the glucolipids: monoacyl-MGlcDAG
  (MAMGlcDAG), monoacyl-DGlcDAG (MADGlcDAG), and monoacyl-bisglycerophosphoryl-DGlcDAG
  (MABGPDGlcDAG) (). However, these lipids have been excluded from the model as they
  are not always synthesized () and their biosynthetic pathways have been postulated,
  but are not known ().'
pmcid: PMC2275695
papertitle: Biophysical Regulation of Lipid Biosynthesis in the Plasma Membrane.
reftext: Stephen H. Alley, et al. Biophys J. 2008 Apr 15;94(8):2938-2954.
pmc_ranked_result_index: '92970'
pathway_score: 0.9503497
filename: BIO.118380.wc.f2.jpg
figtitle: Biophysical Regulation of Lipid Biosynthesis in the Plasma Membrane
year: '2008'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2275695__BIO.118380.wc.f2.html
  '@type': Dataset
  description: 'A. laidlawii lipid biosynthetic network. (A) The biochemical network.
    The main lipids in the plasma membrane of A. laidlawii A-EF22 are (): phosphatidylglycerol
    (PG), diacylglycerol (DAG), monoglucosyl-DAG (MGlcDAG), diglucosyl-DAG (DGlcDAG),
    and glycerophosphoryl-DGlcDAG (GPDGlcDAG). Phosphatidic acid (PA), the liponuleotide
    CDP-DAG, and PG-phosphate (PGP) are lipid intermediates. The top branch is the
    PG pathway and the bottom branch is the glucolipid pathway. The abbreviated soluble
    reactants are glucose (Glc) and UDP-Glc, glycerol-3-phosphate (G3P), the inorganic
    phosphate ions Pi and PPi, and the nucleotide CTP. R indicates an acyl chain.
    Six of the seven enzymes have irreversible rate equations. A. laidlawii also synthesizes
    three monoacyl derivatives of the glucolipids: monoacyl-MGlcDAG (MAMGlcDAG), monoacyl-DGlcDAG
    (MADGlcDAG), and monoacyl-bisglycerophosphoryl-DGlcDAG (MABGPDGlcDAG) (). However,
    these lipids have been excluded from the model as they are not always synthesized
    () and their biosynthetic pathways have been postulated, but are not known ().
    (B) A biophysical picture of the network. Lipids are color coded according to
    their Js, which is linked to their molecular shape as shown. The same color code
    is used to show that the activity of MGS and DGS increases when the plasma membrane
    has a large negative  It can be seen, for instance, that in the case of the lower
    pathway the effect of MGS and DGS is to increase the effective size of the headgroup
    of the lipid upon which they are acting and therefore systematically increase
    the value of Js among DAG, MGlcDAG, and DGlcDAG. By controlling the rate of the
    steps between DAG/MGlcDAG and MGlcDAG/DGlcDAG, the system is capable of regulating
    A. laidlawii also synthesizes three monoacyl-derivatives of the glucolipids: monoacyl-MGlcDAG
    (MAMGlcDAG), monoacyl-DGlcDAG (MADGlcDAG), and monoacyl-bisglycerophosphoryl-DGlcDAG
    (MABGPDGlcDAG) (). However, these lipids have been excluded from the model as
    they are not always synthesized () and their biosynthetic pathways have been postulated,
    but are not known ().'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MATN1
  - SLC25A1
  - LPA
  - REG3A
  - PGP
  - CDP
  - Fatty acid
  - UDP
genes:
- word: CMP
  symbol: CMP
  source: hgnc_prev_symbol
  hgnc_symbol: MATN1
  entrez: '4146'
- word: CTP
  symbol: CTP
  source: hgnc_alias_symbol
  hgnc_symbol: SLC25A1
  entrez: '6576'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: PAP
  symbol: PAP
  source: hgnc_prev_symbol
  hgnc_symbol: REG3A
  entrez: '5068'
- word: PGP
  symbol: PGP
  source: hgnc_symbol
  hgnc_symbol: PGP
  entrez: '283871'
chemicals:
- word: CDP
  source: MESH
  identifier: D003565
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: UDP
  source: MESH
  identifier: D014530
diseases: []
figid_alias: PMC2275695__F2
redirect_from: /figures/PMC2275695__F2
figtype: Figure
---
